ESR1 and breast cancer: Furthermore, Torres et al. [9,33] have shown that AFPep was effective against ER-positive primary canine mammary cancer cells growing in culture, suggesting that these types of cancers are likely to be susceptible to the anti-cancer effects of AFPep in vivo.